Thanks for your thoughts. One correction and my thoughts. Biocells does about $1.5M a year in revenue at about a 10% profit margin. Not bad for a market that has yet really taken hold. My other comment is simple. I predict Matt will buy his way to profitability by the end of this year. And not just profitable, but surprisingly profitable (after consolidation of course). As with all deals it could take longer than hoped/expected, but I'll stick to by the end of this year. Time will tell and I hope I'm correct.
Don't worry about the mule going blind just load the wagon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.